Loading...

EQ EQUILLIUM INC Capital Structure Changes 8-K Filing

QLLM

Q

EQUILLIUM INC

(EQ)

2025 8-K

Quarterly Results

Accounting Firm Engagement

Management Changes

Stock Offering Announcement

Compliance Regained

Equity Offerings

Noncompliance Notice

Equity Incentive Plan amend...

Financial Statements

Financial Results

Clinical Trial Results

Nasdaq Noncompliance

Q3 Financial Results

Itolizumab Update

Nasdaq Compliance

Financial Condition

Phase 2 Study Results

Annual Meeting of Stockholders

Financial Results Announcement

Positive Data from Phase 1b...

Financial Results Announcement

Appointment of Principal Ac...

Results of Operations and F...

Compliance Regained

EQ101 Phase 2 Study Enrollm...

Financial Results and Study...

Equillium Investor Day

Open Market Sale Agreement

Earnings Reports

Termination of Loan Agreement

Annual Meeting of Stockholders

Financial Results Announcement

Financial Results Announcement

External Links:

On August 3, 2025, Equillium, Inc. amended its Open Market Sale Agreement, replacing Jefferies LLC with LifeSci Capital LLC as the sales agent, and announced that it had approximately $11.5 million in cash as of June 30, 2025. The company plans to implement a cryptocurrency treasury reserve strategy to support its financial growth, with the expectation that its current cash reserves will fund operations into Q4 2025.

AI Assistant

EQUILLIUM INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.